Your browser doesn't support javascript.
loading
Combination of panax ginseng and ginkgo biloba extracts attenuate cerebral ischemia injury with modulation of NLRP3 inflammasome and CAMK4/CREB pathway.
Zhao, Aimei; Liu, Nan; Jiang, Guozhi; Xu, Li; Yao, Mingjiang; Zhang, Yehao; Xue, Bingjie; Ma, Bo; Chang, Dennis; Feng, Yujing; Jiang, Yunyao; Liu, Jianxun; Zhou, Guoping.
Afiliación
  • Zhao A; Department of Acupuncture and Moxibustion, Neuroscience Centre, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Liu N; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Jiang G; Beijing Increasepharm Safety and Efficacy Co. Ltd., Beijing, China.
  • Xu L; Shineway Pharmaceutical Group Co. Ltd., Shijiazhuang, China.
  • Yao M; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhang Y; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Xue B; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Ma B; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Chang D; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • Feng Y; NICM, Western Sydney University, Penrith, NSW, Australia.
  • Jiang Y; Department of Anesthesiology, Punan Hospital, Shanghai, China.
  • Liu J; School of Pharmaceutical Sciences, Institute for Chinese Materia Medica, Tsinghua University, Beijing, China.
  • Zhou G; Beijing Key Laboratory of Pharmacology of Chinese Materia, Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Front Pharmacol ; 13: 980449, 2022.
Article en En | MEDLINE | ID: mdl-36091745
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China